Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Interleukin-6 gene -174G>C and -636G>C promoter polymorphisms and prostate cancer risk.

Molecular biology reports - 1 Jan 2013

Magalhães J F, Cortinhas A J, Albuquerque C M, Baptista C S, Ribeiro R, Viegas Carlos, Matos Augusto, Machado João, Pires Maria A, Guedes-Pinto Henrique, Martins-Bessa A, Leitão J C, Bastos E

Abstract excerpt

Prostate cancer (PCa) is one of the most commonly diagnosed internal malignancies affecting men. Due to the important roles of IL-6 in different physiological and pathophysiological processes, IL-6 polymorphisms may modulate PCa risk. IL-6 -174 G>C (rs 1800795, also designated -236 G>C) and -636 G>C (rs 1800796, also designated -572 G>C) promoter polymorphisms have been implicated in PCa susceptibility, albeit...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interleukin-6

Share to Polymorphism, Single Nucleotide

Share to Population Groups

Share to Promoter Regions, Genetic

Share to Prostatic Neoplasms

Share to Publication Bias

Source

Identifiers

PMID: 23073774
DOI: 10.1007/s11033-012-2079-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Interleukin-6 gene -174G>C and -636G>C promoter polymorphisms and prostate cancer risk.PMID 23073774Read ↗

Interleukins-6 -174G/C (rs1800795) and -572C/G (rs1800796) polymorphisms and prostate cancer risk.Semantic proximity Read ↗

The interleukin-6 -174G/C polymorphism and prostate cancer risk: a systematic review and meta-analysis.Semantic proximity Read ↗

An Interleukin-6 Single Nucleotide Polymorphism and Susceptibility to Prostate Adenocarcinoma and Bone Metastasis in an Iranian PopulationSemantic proximity Read ↗

Interleukin-6 -572G/C polymorphism and prostate cancer susceptibility.Semantic proximity Read ↗

Interleukin-6 promoter variants, prostate cancer risk, and survival.Semantic proximity Read ↗

Role of interleukin-6 gene polymorphisms in the development of prostate cancer.Semantic proximity Read ↗

-174G/C polymorphism in the interleukin-6 promoter is differently associated with prostate cancer incidence depending on race.Semantic proximity Read ↗

Meta-analysis of the role of IL-6 rs1800795 polymorphism in the susceptibility to prostate cancer: Evidence based on 17 studies.Semantic proximity Read ↗

The Role of Interleukin-6 Polymorphism (rs1800795) in Prostate Cancer Development and Progression.Semantic proximity Read ↗

Interleukin-6 polymorphism and prostate cancer risk in population of Eastern Croatia.Semantic proximity Read ↗

Relationship between single nucleotide polymorphisms in -174G/C and -634C/G promoter region of interleukin-6 and prostate cancer.Semantic proximity Read ↗

IL-6 -174G>C polymorphism and cancer risk: a meta-analysis involving 29,377 cases and 37,739 controls.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.